Lymphangiogenesis in Chronic Rejection and Coronary Allograft Vasculopathy: An Emerging Diagnostic and Therapeutic Target?

被引：3
|
作者：
Baldwin, H. Scott [1 ]
Drakos, Stavros G. [2 ,3 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Div Pediat Cardiol, 9435-A MRB 4 Langford,2213 Garland Ave, Nashville, TN 37232 USA
[2] Univ Utah Hlth, Div Cardiovasc Med, Salt Lake City, UT USA
[3] Univ Utah, Sch Med, Salt Lake City, UT 84112 USA
来源：
CIRCULATION | 2018年 / 137卷 / 05期
关键词：
Editorials; allografts; graft rejection; heart transplantation; lymphangiogenesis; lymphoscintigraphy; CARDIAC ALLOGRAFTS; ENDOTHELIAL-CELLS; INJURY; NEOVASCULARIZATION; LYMPHATICS; PODOPLANIN;
D O I：
10.1161/CIRCULATIONAHA.117.031716
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：504 / 507
页数：4
相关论文
共 50 条
  • [1] Emerging therapeutic strategies for the prevention and treatment of chronic allograft rejection
    Häyry, P
    Savolainen, H
    Luoto, NM
    Petrov, L
    Loubtchenkov, M
    Aavik, E
    TRANSPLANTATION PROCEEDINGS, 2000, 32 (03) : 519 - 519
  • [2] KCa3.1 as a potential new target for the prevention of chronic allograft vasculopathy and airway allograft rejection
    Chen, Yi-Je
    Hua, Xiaoqin
    Schrepfer, Sonja
    Kohler, Ralf
    Wulff, Heike
    FASEB JOURNAL, 2011, 25
  • [3] Therapeutic lymphangiogenesis ameliorates established acute lung allograft rejection
    Cui, Ye
    Liu, Kaifeng
    Monzon-Medina, Maria E.
    Padera, Robert F.
    Wang, Hao
    George, Gautam
    Toprak, Demet
    Abdelnour, Elie
    D'Agostino, Emmanuel
    Goldberg, Hilary J.
    Perrella, Mark A.
    Forteza, Rosanna Malbran
    Rosas, Ivan O.
    Visner, Gary
    El-Chemaly, Souheil
    JOURNAL OF CLINICAL INVESTIGATION, 2015, 125 (11): : 4255 - 4268
  • [4] Hedgehog signalling in allograft vasculopathy: a new therapeutic target?
    Rowell, Jasmine
    Lau, Ching-In
    Yanez, Diana C.
    Zhang, Eden
    Crompton, Tessa
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2023, 44 (09) : 558 - 560
  • [5] DIAGNOSTIC AND THERAPEUTIC ASPECTS OF LIVER ALLOGRAFT-REJECTION
    CALMUS, Y
    CONTI, F
    DOUSSET, B
    HOUSSIN, D
    THERAPIE, 1992, 47 (04): : 265 - 272
  • [6] Transplant graft vasculopathy: An emerging target for prevention and treatment of renal allograft dysfunction
    Kang, DH
    Kang, SW
    Jeong, HJ
    Kim, YS
    Yang, CW
    Johnson, RJ
    YONSEI MEDICAL JOURNAL, 2004, 45 (06) : 1053 - 1058
  • [7] Is lymphoid neogenesis a therapeutic target for chronic rejection?
    Thaunat, Olivier
    Patey, Natacha
    Michel, Jean-Baptiste
    Nicoletti, Antonino
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (05) : 1312 - 1313
  • [8] Chronic allograft rejection associated vasculopathy and synthetic biodegradable vascular grafts: A lesson to learn?
    Nieuwenhuis, P
    Hillebrands, JL
    Rozing, J
    CRITICAL REVIEWS IN IMMUNOLOGY, 2000, 20 (01) : 85 - 88
  • [9] Interleukin 21 (IL-21) regulates chronic allograft vasculopathy (CAV) in murine heart allograft rejection
    Khattar, Mithun
    Baum, Caitlin E.
    Schroder, Paul
    Breidenbach, Joshua D.
    Haller, Steven T.
    Chen, Wenhao
    Stepkowski, Stanislaw
    PLOS ONE, 2019, 14 (11):
  • [10] The rejection that defies antirejection drugs-chronic vascular rejection (allograft vasculopathy): The role of terminology and linguistic relativity
    Subbotin, Vladimir M.
    Subotin, Michael, V
    DRUG DISCOVERY TODAY, 2024, 29 (12)
12345